Company profile: Immunicom
1.1 - Company Overview
Company description
- Provider of patented Immunopheresis blood-filtering technology that removes specific blood factors to enable the immune system to fight certain cancers; the LW-02 investigational therapeutic cartridge; the EN-06 cartridge in pre-clinical development; and clinical trials at leading hospitals evaluating LW-02 for triple-negative breast cancer, non-small cell lung cancer, melanoma, and renal cell carcinoma.
Products and services
- Immunopheresis: Patented technology using a blood filtering treatment to remove specific blood factors, enabling the body's immune system to fight certain cancers
- Clinical Trials: Multi-indication ongoing studies at leading hospitals evaluate the LW-02 cartridge in treating triple-negative breast cancer, non-small cell lung cancer, melanoma, and renal cell carcinoma
- LW-02 Cartridge: Investigational therapeutic device used in Immunopheresis therapy to remove specific blood factors that prevent the immune system from fighting certain cancers
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Immunicom
BioLife Solutions
HQ: United States
Website
- Description: Provider of cryopreservation media, hypothermic storage/shipping solutions, automated thawing systems, temperature-controlled biostorage services, and human platelet lysates for cell culture. Products include CryoStor (-70 to -196°C freeze media), HypoThermosol (2–8°C, serum/protein-free), ThawSTAR (water-free, standardized thawing), SciSafe Storage Solutions, Stemulate (xeno/heparin-free), and nLiven PR (GMP-ready, pathogen-reduced).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLife Solutions company profile →
DiscoverX
HQ: United States
Website
- Description: Provider of reagents, complete cell-based assay kits, profiling and screening services, and other turn-key solutions for the drug discovery, screening, and life science markets, offering biochemical and cell-based assays to improve research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiscoverX company profile →
ATDBio
HQ: United Kingdom
Website
- Description: Provider of specialized, large-scale DNA and RNA oligonucleotide production and innovation expertise.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ATDBio company profile →
FEI
HQ: United States
Website
- Description: Provider of high-performance microscopy workflow solutions, designing, manufacturing, and supporting electron microscopes and FIB-SEM instruments for nanoscale imaging and sample preparation; Ion Torrent next-generation sequencing systems; monoclonal antibody development and support services; Thermo Scientific laboratory equipment; and custom and bulk lab chemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FEI company profile →
Pfeiffer Vacuum
HQ: Germany
Website
- Description: Provider of vacuum solutions, offering hybrid and magnetically levitated turbopumps; vacuum and backing pumps (rotary vane, Roots, turbomolecular); precise vacuum gauges (Pirani, Bayard-Alpert); PrismaPro mass spectrometers; helium/air leak detectors; valves, flanges, customized vacuum chambers; and integrated vacuum systems for semiconductor contamination management and die casting (Vacu2).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pfeiffer Vacuum company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Immunicom
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Immunicom
2.2 - Growth funds investing in similar companies to Immunicom
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Immunicom
4.2 - Public trading comparable groups for Immunicom
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →